KKR Earnings Preview: Options Hedges Build as Analysts Trim Targets

KKR reports Q3 results on October 30 with options traders running notably more defensive than at any point in the past year, even as the stock has recovered ground and the borrow market shows no trace of stress.

The put/call ratio has eased slightly from its recent peak but remains elevated at 2.17, above the 52-week high of 2.28 reached earlier this month. That compares to a 20-day average of 1.99, placing current positioning about 1.2 standard deviations above the norm. The move into puts accelerated after October 16, when the ratio jumped sharply from the 1.88 range it had held through most of the month. The stock itself closed at $91.62, up 5.3% over the past week, broadly in line with the peer group median. The borrow market reflects none of the options-side caution: shares available to lend remain extraordinarily plentiful, with availability at the platform ceiling and cost to borrow at just 0.39%.

The analyst community has been trimming targets heading into the print, though conviction on direction has not shifted. Barclays cut its target to $127 on October 26, following similar reductions from Piper Sandler, UBS, and TD Cowen over the preceding two weeks. None changed their ratings: the reductions reflect a tighter near-term earnings profile rather than a change of view. The mean target across the Street stands at $121.43, still roughly 33% above the current price. The core disagreement is about timing. The bull case rests on KKR's fundraising trajectory, with fee-bearing capital at $615 billion, management fees up 30% and FRE margins near 70%, creating a durable compounding engine through the fundraising supercycle. Bears point to the reset of the $7 ANI per share goal for 2026, slower exit activity, share count dilution from executive grants, and spread compression at insurance subsidiary Global Atlantic, with insurance operating earnings expected to grow only 1% this year.

Ownership context adds some texture. Two co-CEOs, Joseph Bae and Scott Nuttall, along with director Timothy Barakett and director Mary Dillon, all made open-market purchases in February and March at prices between $87.81 and $94.47 per share. The stock now trades within that purchase range, meaning those positions are roughly at breakeven. The net insider position over the past 90 days is modestly negative at minus 10,000 shares, reflecting the Chief Administrative Officer's September sale of 10,000 shares at $108.58, after exercising options. The founders, George Roberts and Henry Kravis, each hold more than 9% and reported no change in their last filings.

The print will test whether management can demonstrate progress toward the revised earnings trajectory, or whether further guidance resets confirm the bear thesis that near-term KKR earnings growth has been fundamentally disrupted rather than merely delayed.